Skip to main content

More Virtual Posters

AbbVie March 2025

Sponsored by AbbVie Medical Affairs + Health Impact

Long-term maintenance of response of an IL-23i in PsA

AbbVie March 2025

Sponsored by AbbVie Medical Affairs + Health Impact

Time to first musculoskeletal response of an IL-23i in PsA

Abbvie Zoster Virtual Poster

Sponsored by AbbVie Medical Affairs

Zoster vaccine immunogenicity with JAKi treatment

AbbVie Poster (Sept 2024)

Sponsored by AbbVie Medical Affairs

Safety of a JAKi Across 15,000 Patient-Years of Data

×